Join us on our journey as we pioneer the future of

Pharmaceutical Innovation at SynthiMed Labs

 

 

EMPOWERING HEALTHCARE.

ENRICHING LIVES.

With our company’s recent acquisition, of Indswift Labs we honor our predecessor’s

long legacy while embracing growth and evolution.

 

 

PRESERVING LEGACY WHILE FUELING PROGRESS..

 

Synthimed is commited to improving health and well-being 

through pioneering research and development efforts.

ADVANCING WELLNESS THROUGH INNOVATION.

EMBRACING A LEGACY

Synthimed Labs Private Limited proudly takes on the legacy of Ind-Swift Laboratories Ltd., drawing inspiration from the remarkable Indian Swiftlet – a symbol of unmatched speed, endurance, and unwavering ambition. This transition marks the beginning of a new chapter, dedicated to upholding the values of speed, growth, and perseverance.

OUR JOURNEY CONTINUES…

 

We are thrilled to announce that our pharmaceutical company has acquired Indswift Labs, and infused with significant investment, propelling us into an exciting new era of innovation and growth.

As we embark on this transformative journey, our unwavering commitment to excellence in pharmaceutical research, development, and production remains at the forefront of our mission. With this new investment, we are poised to expand our capabilities and deliver even more life-changing medications to those in need.

WHAT WE DO

API’s

CRAMS

IMPURITIES

R & D

Our Capabilties

State-of-the-art Manufacturing

Synthimed boasts state-of-the-art, integrated manufacturing sites that have garnered endorsements and approvals from prominent regulatory bodies worldwide, including the esteemed US Food and Drug Administration (USFDA).

Research & Development

We own a specialized Research Facility capable of managing a diverse range of complex research operations with the objective of continuously enhancing and introducing new products and process technologies.

Human Resources

We have curated a pool of skills, knowledge, talent, aptitude, and competencies through our workforce of over 3000 employees. Our employees bring a wealth of expertise and experience, enabling us to innovate and excel in serving our customers worldwide.

Global Accreditations

Synthimed, holds noteworthy global accreditations from regulatory agencies such as USFDA, EDQM, ANVISA, and KFDA, among others. These accreditations showcase our company’s commitment to maintaining high-quality standards and regulatory compliance, ensuring that its products meet the global standards of quality and regulatory requirements. 

Pioneering HealthCARE Solutions for Tomorrow

Our unwavering commitment to excellence in pharmaceutical research, development, and production remains at the forefront of our mission. With this new investment, we are poised to expand our capabilities and deliver even more life-changing medications to those in need.

EXPERIENCE

Years in the Pharma Industry

GLOBAL PRESENCE

Countries We Serve

FACILITIES

Manufacturing Sites

HUMAN RESOURCE

Skilled Employees

QUALITY

International Accreditations

R&D

sqft Research & Development Centre

EXPLORE OUR PORTFOLIO

Our company has cutting-edge manufacturing facilities that allow us to meet our global goals. With a focus on obtaining consistent regulatory approvals, our products are now being distributed worldwide. Synthimed Labs, a rapidly expanding pharmaceutical company, strives to become a leading player in the global industry, and change the face of healthcare.

CarDIOVASCULAR HEALTH

ANTI-HISTAMINE

ANTI-DIABETIC

ANTI-PSYCHOTIC

ANTI- MIGRAINE

PARKINSON'S DISEASE

ANTINEOPLASTIC

ADHD SYMPTOMS

ALCOHOL ABSTINENCE

BoNE RESORPTION INHIBITOR

GLOBAL LEADER in

MACROLIDE ANTIBIOTIC SEGMENT

 

 

ESG

Synthimed’s Commitment to Sustainability

At Synthimed, our dedication to sustainability permeates every aspect of our operations. We are guided by robust policies, stringent environmental standards, dedicated in-house teams, and a culture of continuous auditing and monitoring, all aimed at upholding the principles of corporate responsibility. Our commitment to fostering sustainability goes beyond mere compliance; it is ingrained in our organizational ethos and influences every decision we make.

GLOBAL REACH

With its diverse range of high-quality products and a strong commitment to regulatory standards, Synthimed’s pharmaceutical offerings cater to the needs of a wide-ranging global customer base. Moreover, the recent acquisition of the API and CRAMS businesses of Ind-Swift Laboratories reaffirms Synthimed’s strategic efforts to enhance its global presence and serve customers with top-notch pharmaceutical products and services

Synthimed Global Reach Placeholder
Synthimed Global Reach